Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes

Claudia H.T. Tam,Cadmon K.P. Lim,Andrea O.Y. Luk,Mai Shi,Hoi Man Cheung,Alex C.W. Ng,Heung-man Lee,Eric S.H. Lau,Baoqi Fan,Guozhi Jiang,Alice P.S. Kong,Risa Ozaki,Elaine Y.K. Chow,Ka Fai Lee,Shing Chung Siu,Grace Hui,Chiu Chi Tsang,Kam Piu Lau,Jenny Y.Y. Leung,Elaine Y.N. Cheung,Man Wo Tsang,Grace Kam,Ip Tim Lau,June K.Y. Li,Vincent T.F. Yeung,Emmy Lau,Stanley Lo,Samuel Fung,Yuk Lun Cheng,Chun Chung Chow,Xiaodan Fan,Ting Fung Chan,Kevin Y.L. Yip,Si Lok,Weichuan Yu,Stephen K.W. Tsui,Hui-yao Lan,Cheuk Chun Szeto,Nelson L.S. Tang,Brian Tomlinson,Yu Huang,Alicia J. Jenkins,Anthony Keech,Wing-yee So,Juliana C.N. Chan,Juliana C.N. Chan,Risa Ozaki,Andrea O.Y. Luk,Wingyee So,Ka-fai Lee,Shing-chung Siu,Grace Hui,Chiu-chi Tsang,Kam-piu Lau,Jenny Y.Y. Leung,Man-wo Tsang,Grace Kam,Elaine Cheung,Ip-tim Lau,June K.Y. Li,Vincent T.F. Yeung,Jo Jo Kwan,Samuel Fung,Stanley Lo,Emmy Lau,Yuk-lun Cheng,Stephen K.W. Tsui,Yu Huang,Huiyao Lan,Weichuan Yu,Brian Tomlinson,Si Lok,Ting-fung Chan,Kevin Y.L. Yip,Cheuk-chun Szeto,Xiaodan Fan,Nelson L.S. Tang,Xiaoyu Tian,Claudia H.T. Tam,Guozhi Jiang,Shi Mai,Baoqi Fan,Fei Xie,Sen Zhang,Pu Yu,Meng Wang,Heung-man Lee,Cadmon K.P. Lim,Fangying Xie,Alex C.W. Ng,Grace P.Y. Cheung,Alice P.S. Kong,Elaine Y.K. Chow,Ming-wai Yeung,Chun-chung Chow,Kitty K.T. Cheung,Rebecca Y.M. Wong,Honcheong So,Katie K.H. Chan,Chin-san Law,Anthea K.Y. Lock,Ingrid K.Y. Tsang,Susanna C.P. Chan,Yin-wah Chan,Cherry Chiu,Chi-sang Hung,Cheuk-wah Ho,Ivy H.Y. Ng,Maria W.H. Mak,Kai-man Lee,Candy H.S. Leung,Ka-wah Lee,Hui-ming Chan,Winnie Wat,Tracy Lau,Cheuk-yiu Law,Ryan H.Y. Chan,Candice Lau,Pearl Tsang,Vince Chan,Lap-ying Ho,Eva Wong,Josephine Chan,Sau-fung Lam,Jessy Pang,Yee-mui Lee,Juliana C.N. Chan,Yu Huang,Hui-yao Lan,Si Lok,Brian Tomlinson,Stephen K.W. Tsui,Weichuan Yu,Kevin Y.L. Yip,Ting-fung Chan,Xiaodan Fan,Wing-yee So,Cheuk-chun Szeto,Nelson L.S. Tang,Andrea O.Y. Luk,Xiaoyu Tian,Claudia H.T. Tam,Guozhi Jiang,Heung Man Lee,Cadmon K.P. Lim,Katie K.H. Chan,Fangying Xie,Alex C.W. Ng,Grace P.Y. Cheung,Ming-wai Yeung,Shi Mai,Fei Xie,Wei Jiang,Sen Zhang,Pu Yu,Meng Weng,Kelly Y. Li,Chuiguo Huang,Gechang Yu,Ronald C.W. Ma,Ronald C.W. Ma,Ronald C.W. Ma,,

DOI: https://doi.org/10.2337/dc22-2331

2023-05-01

Diabetes Care

Abstract:OBJECTIVE In this study we aim to unravel genetic determinants of coronary heart disease (CHD) in type 2 diabetes (T2D) and explore their applications. RESEARCH DESIGN AND METHODS We performed a two-stage genome-wide association study for CHD in Chinese patients with T2D (3,596 case and 8,898 control subjects), followed by replications in European patients with T2D (764 case and 4,276 control subjects) and general populations (n = 51,442–547,261). Each identified variant was examined for its association with a wide range of phenotypes and its interactions with glycemic, blood pressure (BP), and lipid controls in incident cardiovascular diseases. RESULTS We identified a novel variant (rs10171703) for CHD (odds ratio 1.21 [95% CI 1.13–1.30]; P = 2.4 × 10−8) and BP (β ± SE 0.130 ± 0.017; P = 4.1 × 10−14) at PDE1A in Chinese T2D patients but found only a modest association with CHD in general populations. This variant modulated the effects of BP goal attainment (130/80 mmHg) on CHD (Pinteraction = 0.0155) and myocardial infarction (MI) (Pinteraction = 5.1 × 10−4). Patients with CC genotype of rs10171703 had >40% reduction in either cardiovascular events in response to BP control (2.9 × 10−8 < P < 3.6 × 10−5), those with CT genotype had no difference (0.0726 < P < 0.2614), and those with TT genotype had a threefold increase in MI risk (P = 6.7 × 10−3). CONCLUSIONS We discovered a novel CHD- and BP-related variant at PDE1A that interacted with BP goal attainment with divergent effects on CHD risk in Chinese patients with T2D. Incorporating this information may facilitate individualized treatment strategies for precision care in diabetes, only when our findings are validated.

endocrinology & metabolism